Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Monte Rosa Therapeutics (GLUE) Asset Utilization Ratio (2024 - 2025)

Historic Asset Utilization Ratio for Monte Rosa Therapeutics (GLUE) over the last 2 years, with Q3 2025 value amounting to 0.44.

  • Monte Rosa Therapeutics' Asset Utilization Ratio rose 87522.25% to 0.44 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.44, marking a year-over-year increase of 87522.25%. This contributed to the annual value of 0.2 for FY2024, which is N/A changed from last year.
  • Per Monte Rosa Therapeutics' latest filing, its Asset Utilization Ratio stood at 0.44 for Q3 2025, which was up 87522.25% from 0.47 recorded in Q2 2025.
  • Monte Rosa Therapeutics' 5-year Asset Utilization Ratio high stood at 0.47 for Q2 2025, and its period low was 0.0 during Q1 2024.